Spectrum Spine acquired a proprietary surface technology for spinal trauma and has begun operations with the device.
BIOBraille™ is protected by 14 related patents and is exclusively licensed to Spectrum Spine. It integrates prescriptive laser technology and is designed to improve outcomes in spinal operations.
BIOBraille surface technology will be added to Spectrum Spine's portfolio of spinal solutions that includes the Bridge™ MIS tubular approach Laminoplasty System, shown above, which is designed to preserve nerve, vasculature and muscle tissue; reduce operative complications and restore function.
The technology can provide bone growth activation in spinal and orthopedic devices that may reduce inflammation, speed the process of strong and durable fusion and lead to superior outcomes for patients having spinal surgery.